Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atomoxetine Hydrochloride”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00255138
What this trial is testing

Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

Who this might be right for
CancerCognitive Late Effects
Temple University
Large-scale testing (Phase 3)Study completedNCT00191880
What this trial is testing

Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 100
Post-approval studies (Phase 4)Study completedNCT00183391
What this trial is testing

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Icahn School of Medicine at Mount Sinai 232
Post-approval studies (Phase 4)Looking for participantsNCT06573970
What this trial is testing

Atomoxetine and Executive Function in PTSD

Who this might be right for
Posttraumatic Stress Disorder With Attention Defic
VA Office of Research and Development 160
Post-approval studies (Phase 4)Study completedNCT00222794
What this trial is testing

A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Pittsburgh 66
Testing effectiveness (Phase 2)Study completedNCT06400615
What this trial is testing

Study That Tests AD109 in Patients Taking GLP-1 Drugs

Who this might be right for
OSA
Apnimed 40
Post-approval studies (Phase 4)Study completedNCT00254462
What this trial is testing

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

Who this might be right for
Attention Deficit Disorder With Hyperactivity
University of Nebraska 93
Testing effectiveness (Phase 2)Study completedNCT03091400
What this trial is testing

Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)

Who this might be right for
Memory DisordersMultiple Sclerosis
Icahn School of Medicine at Mount Sinai 11
Post-approval studies (Phase 4)Study completedNCT00471354
What this trial is testing

Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 228
Testing effectiveness (Phase 2)Study completedNCT01557569
What this trial is testing

Clinical Efficacy of Atomoxetine for Methamphetamine Dependence

Who this might be right for
Methamphetamine Dependence
University of Arkansas 20
Early research (Phase 1)Study completedNCT00417794
What this trial is testing

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

Who this might be right for
Fetal Alcohol SyndromeAttention Deficit Disorder With Hyperactivity (ADHD)Attention Deficit Disorder (ADD)
University of Oklahoma 38
Testing effectiveness (Phase 2)Study completedNCT00420498
What this trial is testing

Effects of Atomoxetine on Cognitive Function in Schizophrenia

Who this might be right for
SchizophreniaCognitionSmoking
Yale University 12
Large-scale testing (Phase 3)Study completedNCT00191295
What this trial is testing

Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 240
Post-approval studies (Phase 4)WithdrawnNCT01207622
What this trial is testing

Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD

Who this might be right for
Attention Deficit Hyperactivity DisorderSubstance Use Disorder
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT00191542
What this trial is testing

Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 100
Large-scale testing (Phase 3)Study completedNCT00192023
What this trial is testing

An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).

Who this might be right for
Attention Deficit Hyperactivity DisorderOppositional Defiant Disorder
Eli Lilly and Company 139
Large-scale testing (Phase 3)Study completedNCT00447278
What this trial is testing

A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 399
Post-approval studies (Phase 4)Study completedNCT00191906
What this trial is testing

Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

Who this might be right for
Attention Deficit Hyperactivity DisorderReading Disorder
Eli Lilly and Company 121
Not applicableUnknownNCT05229627
What this trial is testing

Multimodal Magnetic Resonance Imaging Study on the Neural Mechanisms of Remission in Children With ADHD

Who this might be right for
ADHD
Peking University Sixth Hospital 250
Post-approval studies (Phase 4)Study completedNCT00488163
What this trial is testing

Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia

Who this might be right for
Schizophrenia
Research Foundation for Mental Hygiene, Inc. 20
Next Page